Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805285 · ClinicalTrials.gov registry record · Phase 2
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00805285: Clinical Trial Phase 2 study, sponsored by University of Maryland, Baltimore.
NCT00805285 is a Phase 2 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00805285, a Phase 2 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if the combination of oral budesonide and rectal hydrocortisone improves symptoms in patients with active ulcerative colitis. Also, we would like to determine if oral budesonide and rectal hydrocortisone has fewer and less severe side effects compared to standard steroids (prednisone).
Primary Outcome
Scores range from 0-19. Higher scores indicated increased disease severity. A score less than 3 is consistent with clinical remission.
Interventions
- DRUG Combination Oral Budesonide and Rectal Hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Why NCT00805285 stopped before completion
NCT00805285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Combination Oral Budesonide and Rectal Hydrocortisone is the first listed.
NCT00805285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00805285 about?
NCT00805285 is a clinical study titled "The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis". The purpose of this study is to evaluate if the combination of oral budesonide and rectal hydrocortisone improves symptoms in patients with active ulcerative colitis. Also, we would like to determine if oral budesonide and rectal hydrocortisone has fewer and less severe side effects compared to stan...
What is the current status of trial NCT00805285?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00805285?
The interventions under investigation include: Combination Oral Budesonide and Rectal Hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT00805285?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00805285's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia